The Journal of Practical Medicine ›› 2023, Vol. 39 ›› Issue (24): 3261-3266.doi: 10.3969/j.issn.1006-5725.2023.24.020
• Medical Examination and Clinical Diagnosis • Previous Articles Next Articles
Gang LIU1,Rushu LAN2,Huifang QIN3,Xiaoling QIN1,Yixiang QIN1,Ruolan XU1,Dan. LUO1()
Received:
2023-08-30
Online:
2023-12-25
Published:
2024-01-10
Contact:
Dan. LUO
E-mail:luodan.2005@163.com
CLC Number:
Gang LIU,Rushu LAN,Huifang QIN,Xiaoling QIN,Yixiang QIN,Ruolan XU,Dan. LUO. Mutation characteristics of ethambutol resistance gene of Mycobacterium tuberculosis in Guangxi[J]. The Journal of Practical Medicine, 2023, 39(24): 3261-3266.
Tab.2
Distribution of mutations in ethambutol resistance genes of Mycobacterium tuberculosis"
序号 | 突变位点 | 碱基改变 | 氨基酸改变 | 菌株 | 合计 | 构成比(%) |
---|---|---|---|---|---|---|
单位点突变 | 29 | 53.7% | ||||
1 | embB306 | ATG→GTG | 甲硫氨酸→缬氨酸 | 10 | 19 | 35.19 |
ATG→ATA | 甲硫氨酸→异亮氨酸 | 5 | ||||
ATG→ATC | 甲硫氨酸→异亮氨酸 | 3 | ||||
ATG→ATT | 甲硫氨酸→异亮氨酸 | 1 | ||||
2 | embB497 | CAG→AAG | 谷氨酰胺→赖氨酸 | 1 | 3 | 5.56 |
CAG→CGG | 谷氨酰胺→精氨酸 | 2 | ||||
3 | embB406 | GGC→GCC | 甘氨酸→丙氨酸 | 2 | 2 | 3.70 |
4 | embA | C→A | 半胱氨酸→丙氨酸 | 1 | 1 | 1.85 |
5 | embA-16 | C→T | 半胱氨酸→苏氨酸 | 1 | 1 | 1.85 |
6 | embB354 | GAC→GCC | 天冬氨酸→丙氨酸 | 1 | 1 | 1.85 |
7 | embB370 | GTG→CGG | 缬氨酸→精氨酸 | 1 | 1 | 1.85 |
8 | embB405 | GAG→GAT | 谷氨酸→天冬氨酸 | 1 | 1 | 1.85 |
联合位点突变 | 25 | 46.3% | ||||
1 | embC270+embB378 | ACC→ATC+GAG→GCG | 天冬氨酸→异亮氨酸+谷氨酸→丙氨酸 | 12 | 12 | 22.22 |
2 | embB306+embA-12 | ATG→GTG+C→T | 甲硫氨酸→缬氨酸+半胱氨酸→苏氨酸 | 1 | 2 | 3.70 |
ATG→ATC+C→T | 甲硫氨酸→异亮氨酸+半胱氨酸→苏氨酸 | 1 | ||||
3 | embB306+embB1024 | ATA→GTG+GAC→AAC | 异亮氨酸→缬氨酸+天冬氨酸→天冬酰胺 | 1 | 1 | 1.85 |
4 | embB306+embB319 | ATG→GTG+TAT→TGT | 甲硫氨酸→缬氨酸+酪氨酸→半胱氨酸 | 1 | 1 | 1.85 |
5 | embB306+embB406 | ATG→ATA+GGC→GCC | 甲硫氨酸→异亮氨酸+甘氨酸→丙氨酸 | 1 | 1 | 1.85 |
ATG→ATA+GGC→GAC | 甲硫氨酸→异亮氨酸+甘氨酸→天冬氨酸 | 1 | 1 | 1.85 | ||
6 | embB328+embB306 | GAT→GGT+ATG→GTG | 天冬氨酸→甘氨酸+甲硫氨酸→缬氨酸 | 1 | 1 | 1.85 |
7 | embB354+embB1024 | GAC→GCC+GAC→AAC | 天冬氨酸→丙氨酸+天冬氨酸→天冬酰胺 | 1 | 1 | 1.85 |
8 | embB497+embA-12 | CAG→CCG+C→T | 谷氨酰胺→脯氨酸+半胱氨酸→苏氨酸 | 1 | 1 | 1.85 |
9 | embC270+embB312 | ACC→ATC+CAC→CGC | 苏氨酸→异亮氨酸+组氨酸→精氨酸 | 1 | 1 | 1.85 |
10 | embB306+embB406+embB497 | ATG→ATT+GGC→TGC+ CAG→CCG | 甲硫氨酸→异亮氨酸+甘氨酸→半胱氨酸+谷氨酰胺→脯氨酸 | 1 | 1 | 1.85 |
11 | embB317+embB356+embB378+embB388 | TCC→ACC+GCC→GTC+ GAG→GCG+GCC→GGC | 丝氨酸→苏氨酸+丙氨酸→缬氨酸+谷氨酸→丙氨酸+丙氨酸→甘氨酸 | 1 | 1 | 1.85 |
12 | embC270+embB378+embB312+embB356+embB359+embB388+embB399+embB384+embB406 | ACC→ATC+GAG→GCG+ CAC→CGC+GCC-GTC+ CTA→ATA+GCC→GGC+ AAC→GAC+TAC→AAC+ GGC→GCC | 苏氨酸→异亮氨酸+谷氨酸→丙氨酸+组氨酸-精氨酸+丙氨酸→缬氨酸+亮氨酸→异亮氨酸+丙氨酸→甘氨酸+天冬酰胺→天冬氨酸+酪氨酸→天冬酰胺+甘氨酸→丙氨酸 | 1 | 1 | 1.85 |
Tab.3
Analysis of factors associated with mutations in the ethambutol resistance gene of Mycobacterium tuberculosis"
因素 | 全部菌株 (n = 655) | EMB基因 突变菌株(n = 54) | EMB基因 无突变菌株(n = 601) | χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|---|
性别 | ||||||
男 | 510(77.86) | 51(94.44) | 459(76.37) | 9.388 | 0.004 | 5.259(1.617 ~ 17.107) |
女 | 145(22.14) | 3(5.56) | 142(23.63) | 1 | ||
年龄 | ||||||
< 30岁 | 105(16.13) | 4(7.41) | 101(16.81) | 5.210 | 0.074 | 1 |
30 ~ 59岁 | 321(49.01) | 33(61.11) | 288(47.92) | 2.893(1.000 ~ 8.396) | ||
≥ 60岁 | 229(34.96) | 17(31.48) | 212(35.27) | 2.025(0.064 ~ 6.173) | ||
治疗史 | ||||||
初治 | 558(85.19) | 33(61.11) | 525(87.35) | 27.084 | 0.000 | 1 |
复治 | 97(14.81) | 21(38.89) | 76(12.65) | 4.396(2.418 ~ 7.991) | ||
空洞 | ||||||
是 | 639(97.56) | 51(94.44) | 588(97.84) | 2.393 | 0.277 | 0.376(0.104 ~ 1.362) |
否 | 16(2.44) | 3(5.56) | 13(2.16) | 1 | ||
病变累及肺野数 | ||||||
1个 | 59(9.01) | 3(5.56) | 56(9.32) | 0.458 | 0.498 | 1 |
≥ 2个 | 596(90.99) | 51(94.44) | 545(90.68) | 1.747(0.528 ~ 5.779) | ||
基因型 | ||||||
北京型 | 432(65.95) | 27(50.00) | 405(67.39) | 6.671 | 0.010 | 0.484(0.276 ~ 0.847) |
非北京型 | 223(34.05) | 27(50.00) | 196(32.61) | 1 | ||
耐多药 | ||||||
是 | 61(9.31) | 22(40.74) | 39(6.49) | 68.826 | 0.000 | 9.907(5.364 ~ 18.647) |
否 | 594(90.69) | 32(59.26) | 562(93.51) | 1 |
1 | JADAUN G P, DAS R, UPADHYAY P,et al. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India[J]. Int J Antimicrob Agents, 2009,33(5):483-486. |
2 | World Health Organization. Global Tuberculosis Report 2021[R/OL]. (2021-10-14). . |
3 | 张春雷,丁豪帅,康亚芬,等. 结核杆菌特异性细胞免疫与结核抗体辅助诊断男性生殖系统结核的价值[J]. 实用医学杂志,2021,37(20):2670-2674. |
4 | SUN Q, XIAO T Y, LIU H C, et al. Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China[J]. Antimicrob Agents Chemother, 2017,62(1):e01279-17. |
5 | RAMASWAMY S V, AMIN A G, GÖKSEL S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2000,44(2):326-336. |
6 | 赵雁林. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015:39-42,67-70. |
7 | AMINI S, HOFFNER S, ALLAHYAR TORKAMAN M R, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study[J]. J Glob Antimicrob Resist, 2019,17:242-244. |
8 | DE ALMEIDA I N, SILVA CARVALHO W DA, ROSSETTI M L,et al.Evaluation of six different DNA extraction methods for detection of Mycobacterium tuberculosis by means of PCR-IS6110: preliminary study[J]. BMC Res Notes, 2013,6:561. |
9 | WILSON T M. Clinical experience with ethambutol[J]. Antibiot Chemother,1970,(16):222-229. |
10 | AHMAD S, MOKADDAS E, AL-MUTAIRI N, et al. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country[J]. PLoS One, 2016,11(4):e0153563. |
11 | BAKULA Z, NAPIORKOWSKA A, BIELECKI J, et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland[J]. Biomed Res Int, 2013,(2013):167954. |
12 | JIA H, XU Y, SUN Z.Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China[J]. Antibiotics (Basel), 2021,10(11):1367. |
13 | PLINKE C, RUSCH GERDES S, NIEMANN S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates[J]. Antimicrob Agents Chemother, 2006,50(5):1900-1902. |
14 | MOKROUSOV I, OTTEN T, VYSHNEVSKIY B, et al. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing[J]. J Clin Microbiol,2002,40(10):3810-3813. |
15 | SHI D, LI L, ZHAO Y, et al. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China[J]. J Antimicrob Chemother, 2011,66(10):2240-2247. |
16 | SAFI H, LINGARAJU S, AMIN A, et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes[J]. Nat Genet, 2013,45(10):1190-1197. |
17 | KHOSRAVI A D, SIROUS M, ABDI M, et al. Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran[J]. Infect Drug Resist, 2019,12:579-584. |
18 | XIANG X, GONG Z, DENG W, et al. Mycobacterial ethambutol responsive genes and implications in antibiotics resistance[J]. J Drug Target, 2021,29(3):284-293. |
19 | 车洋,杨天池,平国华,等. 宁波地区耐多药结核分枝杆菌乙胺丁醇耐药embB基因突变研究[J]. 中国预防医学杂志, 2018,19(7):505-508. |
20 | 刘厚明,曾敏,李全,等. embB基因突变与乙胺丁醇药敏表型及耐多药关系的研究[J]. 分子诊断与治疗杂志, 2017,9(1):16-22,32. |
21 | XU Y, JIA H, HUANG H, et al. Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China[J]. Biomed Res Int, 2015,2015:951706. |
22 | SAFI H, FLEISCHMANN R D, PETERSON S N, et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2010,54(1):103-108. |
23 | 吴坤阳,陆烨玮,张明五,等. 浙江省结核分枝杆菌耐药突变特征及其与基因型相关性分析[J]. 中国防痨杂志, 2022,44(11):1126-1134. |
24 | 孙庆. 结核分枝杆菌乙胺丁醇耐药性与分子特征的相关性研究[D]. 衡阳:南华大学, 2015. |
25 | 刘翠玉,历素萍,潘宝山,等. 2017-2020年黑龙江省佳木斯市肺结核患者耐药情况分析[J]. 疾病监测, 2021,36(10):1052-1056. |
26 | 郑扬,赵雁林. 初、复治患者结核分枝杆菌临床分离株对抗结核药物耐药性的分析[J]. 医学研究杂志, 2017,46(4):22-27. |
27 | MOHAMMADI B, RAMAZANZADEH R, NOURI B,et al. Frequency of Codon 306 Mutations in embB Gene of Mycobacterium tuberculosis Resistant to Ethambutol: A Systematic Review and Meta-Analysis[J]. Int J Prev Med, 2020,11:112. |
28 | 徐东芳,刘海灿,赵秀芹,等. 391株结核分枝杆菌基因分型研究和耐药性分析[J]. 中国卫生检验杂志, 2016,26(18):2719-2720,2731. |
[1] | Shiyun WANG,Zhanying TANG,Jie LIN,Qian CHEN,Fangyu LI,Zhengquan YANG,Zhijun. HU. The effect of COMP gene mutation on the clinical efficacy and prognosis of the treatment of carpal tunnel syndrome with ultrasound⁃guided crochet knife [J]. The Journal of Practical Medicine, 2024, 40(8): 1126-1131. |
[2] | Qi CHEN,Yaxi ZHANG,Mingxia ZHANG,Jieyun ZHANG,Qianting. YANG. The detection value of tuberculosis-specific QFT-TB in different types of specimens of tuberculosis patients [J]. The Journal of Practical Medicine, 2024, 40(7): 1002-1005. |
[3] | Xiaotong LIU,Xianhua SU,Zhijun XIN,Fengqiong GAO,Jiayi FENG,Tongxia. XIA. Risk factors of postoperative complications in patients with spinal tuberculosis and the predictive value of prognostic nutritional index [J]. The Journal of Practical Medicine, 2024, 40(7): 972-978. |
[4] | Wenji ZHUO,Ran WEI,Yanmei CHEN,Xunxun CHEN,Meiling YU,Huixin GUO,Hongdi LIANG,Jing LIANG,Xiaoyu. LAI. Drug resistance characteristics and treatment strategies of TB patients in three age groups in Guangdong Province from 2014 to 2020 [J]. The Journal of Practical Medicine, 2024, 40(5): 702-707. |
[5] | Yigang TAN,Haobin KUANG,Hongmei FU,Chunyan LI,Xiaobing ZHAO,Lijing XUE. Analysis of clinical characteristics of 33 cases of tuberculosis complicated by tumor necrosis factor⁃α inhibitor in autoimmune diseases [J]. The Journal of Practical Medicine, 2024, 40(3): 378-383. |
[6] | Qianqian CHEN,Qiuyu LIN,Xiangyun ZHANG,Dufei. ZHANG. Relationship between macrolide⁃resistant mycoplasma pneumoniae infection and refractory Mycoplasma pneumoniae pneumonia in children [J]. The Journal of Practical Medicine, 2024, 40(22): 3190-3195. |
[7] | Linlin GAI,Weice SUN,Jinjin CHU,Donghua XU. Changes of M1/M2 macrophages polarization associated with active pulmonary tuberculosis and the effect of ESAT6 on macrophage polarization [J]. The Journal of Practical Medicine, 2024, 40(20): 2867-2873. |
[8] | Haojie TANG,Zilong YANG,Zhaoxian YU,Zhiyu FENG,Haiping DONG,Xiang LI,Wei ZHAO,Haobin. KUANG. Construction and evaluation of a risk prediction model for linezolid-related neurological adverse reactions in patients with multidrug-resistant tuberculosis [J]. The Journal of Practical Medicine, 2024, 40(19): 2690-2695. |
[9] | Feng ZHU,Qing LI,Xi CHEN,Yang HE,Lei. PENG. Application of FNA combined with next⁃generation sequencing in the diagnosis and treatment of thyroid nodules [J]. The Journal of Practical Medicine, 2024, 40(17): 2471-2476. |
[10] | Shuyu ZHANG,Yuehong. LI. An overview of mycobacterium tuberculosis infection after kidney transplantation [J]. The Journal of Practical Medicine, 2024, 40(15): 2047-2050. |
[11] | Yigang TAN,Honglan ZHONG,Chunming LUO,Xingshan CAI,Bitong WU,Hui FAN,Min. SONG. Clinical analysis of pulmonary tuberculosis complicated with Nocardia farcinica [J]. The Journal of Practical Medicine, 2024, 40(14): 1969-1974. |
[12] | Jing GUI,Feng WANG,Hui YANG,Yumao CAI,Chuangyue. HONG. Investigation of oxidised low⁃density lipoprotein as a risk assessment indicator in patients with type 2 diabetes mellitus combined with pulmonary tuberculosis [J]. The Journal of Practical Medicine, 2024, 40(14): 1995-2002. |
[13] | Wendi ZHOU,Jiamin LIN,Daichen JU,Qi WANG,Jialou ZHU,Ning SU,Jinxing. HU. Proteomic profiling and functional analysis of differentially expressed proteins in lung cancer coexistent with pulmonary tuberculosis [J]. The Journal of Practical Medicine, 2024, 40(13): 1814-1821. |
[14] | Shengming YU,Lianghua XIA,Jiahuan ZHAN,Siqi LIU,Wei WANG,Liang YAN,Kaisen. CHEN. Study on the mutation characteristics of streptomycin genes of Multidrug-Resistant Mycobacterium Tuberculosis in Jiangxi Province [J]. The Journal of Practical Medicine, 2024, 40(1): 91-96. |
[15] | Nenhan WANG,Yanfeng ZHAO,Lili TIAN,Shuangshuang CHEN,Hao CHEN,Yixuan REN,Chuanyou LI,Xiaowei. DAI. Clinical application of fluorescence polymerase chain reaction probe melting curve technique in detecting isoniazid drug⁃resistance of Mycobacterium tuberculosis in sputum samples [J]. The Journal of Practical Medicine, 2023, 39(20): 2664-2670. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||